GMP Secures Major $639.8 Million Contract with U.S. Army
Global Military Products Awarded Contract for Artillery Munitions
A recent achievement by Global Military Products (GMP) showcases its ongoing commitment to providing top-notch defense solutions. GMP has been awarded a substantial firm-fixed-price contract worth $639.8 million by the U.S. Army. This award not only highlights GMP's reliability but also strengthens their collaboration with Rheinmetall Expal Munitions to supply 155mm High Explosive complete rounds.
Significance of the Contract
This contract is a testament to GMP's pivotal role as a trusted supplier for U.S. military needs. The Vice President of Ammunition Programs and Engineering at GMP, Mike Quesenberry, expressed enthusiasm, stating that this signified a major win for GMP. It reflects their ongoing dedication to fulfilling U.S. Army requirements and bringing innovative solutions directly to the military.
Production and Timeline
The production of these high-quality munitions is set to commence in the near future, with expectations to wrap up by July 2027. This timeline demonstrates GMP's readiness to meet the critical operational needs of the U.S. Army. The Army Contracting Command in Rock Island, Illinois, oversees this significant project.
Commitment to Excellence
The recent contract reinforces GMP’s reputation as a primary contractor to the Department of War. This development emphasizes their commitment to delivering reliable ammunition solutions that support the U.S. Army and its missions across the globe. As a subsidiary of Global Ordnance Holdings, GMP is dedicated to ensuring that our armed forces have access to high-quality military supplies.
About Global Military Products (GMP)
Headquartered in Tampa, Florida, Global Military Products operates as a key player in the defense sector. As a wholly-owned subsidiary of Global Ordnance Holdings, GMP provides a wide array of military equipment, including ammunition and weapons systems, to U.S. allies worldwide. Their operations ensure that military needs are met with precision and efficiency.
Contact Information
For further inquiries or information, interested parties may reach out to Michael C. Cherry, the VP of Business Development & Marketing. GMP's dedicated team is available to assist with any questions about their products and services. Contact details include a phone number: 941-899-3047.
Frequently Asked Questions
What is the value of the contract awarded to GMP?
The contract awarded to Global Military Products is valued at $639.8 million.
What type of munitions is GMP supplying?
GMP is supplying 155mm High Explosive complete rounds under the contract with the U.S. Army.
When is the production of these munitions scheduled to start?
Production is scheduled to begin in 2026.
What is the expected completion date for this contract?
The estimated completion date for the contract is July 10, 2027.
Where is Global Military Products headquartered?
Global Military Products is headquartered in Tampa, Florida.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.